Chemours (CC)
NYSE: CC
· Real-Time Price · USD
14.92
0.30 (2.09%)
At close: Aug 18, 2025, 3:59 PM
14.95
0.20%
Pre-market: Aug 19, 2025, 07:00 AM EDT
Chemours Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.61B | 1.37B | 1.39B | 1.5B | 1.54B | 1.35B | 1.36B | 1.49B | 1.64B | 1.54B | 1.34B | 1.78B | 1.92B | 1.76B | 1.57B | 1.68B | 1.66B | 1.44B |
Cost of Revenue | 1.34B | 1.13B | 1.12B | 1.22B | 1.23B | 1.06B | 1.12B | 1.21B | 1.23B | 1.17B | 1.14B | 1.34B | 1.42B | 1.28B | 1.18B | 1.25B | 1.39B | 1.14B |
Gross Profit | 278M | 236M | 273M | 286M | 307M | 286M | 244M | 281M | 410M | 368M | 202M | 432M | 497M | 486M | 393M | 427M | 264M | 297M |
Operating Income | -187M | 78M | 78M | 122M | 142M | 116M | -5M | 88M | -397M | 231M | 16M | 332M | 200M | 330M | 345M | 273M | 59M | 138M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -261M | 78M | 9M | -30M | 82M | 67M | -81M | 23M | -433M | 173M | -69M | 299M | 231M | 280M | 302M | 231M | 44M | 101M |
Net Income | -381M | -4M | -8M | -27M | 70M | 52M | -26M | 20M | -376M | 145M | -97M | 240M | 201M | 234M | 233M | 214M | 66M | 96M |
Selling & General & Admin | 437M | 123M | 169M | 135M | 139M | 142M | 223M | 165M | 779M | 124M | 175M | 140M | 254M | 141M | 159M | 124M | 172M | 139M |
Research & Development | 28M | 27M | 26M | 29M | 26M | 28M | 26M | 28M | 28M | 26M | 30M | 32M | 25M | 30M | 29M | 27M | 27M | 24M |
Other Expenses | n/a | 8M | 3M | n/a | n/a | 1M | n/a | n/a | -2M | 1M | -1M | n/a | n/a | 1M | 132M | n/a | 16M | 1M |
Operating Expenses | 465M | 158M | 198M | 164M | 165M | 174M | 249M | 193M | 807M | 150M | 204M | 172M | 279M | 172M | 182M | 151M | 205M | 163M |
Interest Expense | 66M | 66M | 67M | 69M | 66M | 63M | 63M | 55M | 48M | 42M | 40M | 41M | 40M | 41M | 43M | 45M | 47M | 49M |
Selling & Marketing Expenses | n/a | n/a | 2M | n/a | n/a | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.8B | 1.29B | 1.32B | 1.38B | 1.4B | 1.24B | 1.37B | 1.4B | 2.04B | 1.32B | 1.34B | 1.52B | 1.7B | 1.45B | 1.36B | 1.4B | 1.6B | 1.3B |
Income Tax Expense | 119M | 4M | 17M | -3M | 12M | 15M | -55M | 3M | -57M | 28M | 28M | 59M | 30M | 46M | 69M | 17M | -22M | 5M |
Shares Outstanding (Basic) | 150.24M | 149.92M | 149.83M | 149.7M | 149.41M | 149.04M | 148.59M | 148.62M | 149.1M | 149M | 150.05M | 155.38M | 156.22M | 159.9M | 165.11M | 165.11M | 166.17M | 165.65M |
Shares Outstanding (Diluted) | 150.24M | 150.41M | 149.83M | 149.7M | 150.12M | 150.05M | 148.59M | 150.19M | 149.1M | 151.18M | 150.05M | 157.85M | 159.67M | 163.58M | 168.95M | 168.95M | 170.16M | 169.05M |
EPS (Basic) | -2.54 | -0.03 | -0.05 | -0.18 | 0.47 | 0.35 | -0.17 | 0.13 | -2.52 | 0.97 | -0.65 | 1.54 | 1.29 | 1.46 | 1.41 | 1.30 | 0.40 | 0.58 |
EPS (Diluted) | -2.54 | -0.03 | -0.05 | -0.18 | 0.47 | 0.34 | -0.17 | 0.13 | -2.52 | 0.96 | -0.65 | 1.52 | 1.26 | 1.43 | 1.38 | 1.27 | 0.39 | 0.57 |
EBITDA | -187M | 154M | 153M | 117M | 216M | 186M | 52M | 144M | -307M | 310M | 45M | 403M | 272M | 404M | 281M | 355M | 172M | 218M |
EBIT | -195M | 66M | 75M | 39M | 128M | 130M | -22M | 68M | -385M | 215M | -29M | 340M | 220M | 321M | 206M | 278M | 91M | 135M |
Depreciation & Amortization | 91M | 88M | 78M | 78M | 74M | 71M | 74M | 76M | 78M | 79M | 74M | 72M | 72M | 74M | 75M | 79M | 80M | 83M |